Trifluoperazine (TFP) is a potent antipsychotic agent, dibucaine (DBC) is a
local anaesthetic and praziquantel (PZQ) is a highly effective agent again
st schistosomiasis. The present work was conducted to (i) investigate the c
ytotoxic effects of TFP, DEC and PZQ on human erythrocyte membranes; and (i
i) compare the alterations induced by the cationic drugs (TFP and DEC) with
those induced by the uncharged compound (PZQ), in an attempt to have a bet
ter insight on the pathways of each drug-membrane interaction. The erythroc
yte morphological alterations induced by sublytic concentrations of TFP, DE
C and PZQ were evaluated by scanning electron microscopy and expressed quan
titatively by the morphological index. Haemolysis and release of membrane l
ipids (phospholipids and cholesterol) produced by selected concentrations o
f TFP, DEC and PZQ, were compared with those resulting from the correspondi
ng triple concentrations of each drug. Our results showed that the uncharge
d molecule of PZQ induces the same morphological alterations (stomatocytosi
s) as the cationic drugs TFP and DEC. Haemolysis was shown to vary with the
drug used and to be concentration-dependent, with values similar to 10-fol
d more elevated for TFP and DEC than for PZQ, which revealed st maximum of
6% haemolysis for the highest concentration tested. Different concentration
-response curves were obtained for lipid elution, although the profiles of
cholesterol and phospholipids released were similar for all drugs. Neverthe
less, at a fixed rate of 50% haemolysis, TFP induced a similar to 2-fold in
crement in the elution of cholesterol when compared with that produced by D
EC (P < 0.05). The different effects induced by TFP, DEC and PZQ on erythro
cyte morphology, haemolysis and lipid exfoliation are related to the physic
al and chemical characteristics of each compound. These results suggest tha
t distinct cell membrane interaction pathways lead to drug-specific mechani
sms of cytotoxicity. (C) 2000 Elsevier Science Ireland Ltd. All rights rese
rved.